Strahlman Ellen R sold $145K of MO

Strahlman Ellen R sold 2,000 shares of ALTRIA GROUP, INC. (MO) at $72.56 ($0.15M total) on 2026-05-26.

Original reporting
SEC EDGAR · Strahlman Ellen R
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MO
Neutral
medium confidence
Mentioned
$MO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MONeutralLow
01

Why it matters

Insider selling can be interpreted as mild negative sentiment, but without accompanying company-specific news, it typically does not change valuation drivers.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new fundamental catalyst in the text.

03

What to watch

The article provides only the sale details, not the director’s broader trading history, remaining compensation structure, or whether other insiders sold/bought around the same time.

Relevance 4/10Novelty 3/10Timing: filed 2026-05-28, transaction dated 2026-05-26

Background

The article is an SEC Form 4 insider transaction disclosure for Altria Group, Inc. (MO) by director Strahlman Ellen R.

Company-level read

Ticker impact

$MONeutralMedium confidence
Context

Altria director Strahlman Ellen R sold 2,000 shares in an open-market transaction for about $145,118, per a fresh Form 4 filing.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and small versus normal MO trading flows.

Evidence & confidence

The filing discloses transaction size, price, and that it was not under a pre-arranged 10b5-1 plan, but provides no new operational, financial, or regulatory information.

Market effects

No clear read-through to tobacco sector fundamentals from a single director sale.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan does not necessarily imply negative expectations; sales can be driven by diversification, taxes, or pre-existing personal liquidity needs.

Key entities

  • Altria Group, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Strahlman Ellen R

    Director who sold 2,000 shares at $72.5590 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MOHighAI 8/10

Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?

Altria (MO), Gilead (GILD), and ExxonMobil (XOM) reached 52-week highs after strong Q3 results. MO reported $1.52 EPS, raised guidance, and increased buybacks. GILD exceeded revenue/earnings expectations, boosting HIV growth outlook. XOM posted $4.23 EPS, raised dividend, and maintained buyback plan. All three stocks gained 1-3% on the day.

$MOHighAI 8/10

America’s Greatest Dividend Posts Strong Earnings

Altria (MO) reported Q3 revenue of $6.1B (+1% YoY) and EPS of $1.51 (+7% YoY), beating expectations. The company raised its full-year earnings guidance, citing strong performance. Shares rose 6% over two days and are up 33% YTD. CEO Sal Mancuso highlighted confidence in the full-year plan. Marlboro, with a 40% U.S. market share, drives most revenue. Other high-yield companies like UPS, Kraft Heinz, and General Mills face economic sensitivity and competition.

$MOMed

Goldman Sees More Upside in Altria After Strong Quarter

Goldman Sachs raised its price target for Altria (MO) to $83 from $77, citing better-than-expected Q3 earnings and revenue. Adjusted EPS was $1.52, beating estimates, and revenue reached $6.13B. Management increased its 2026 EPS growth outlook. Goldman expects continued benefits from tax drawbacks and a manufacturing agreement with Philip Morris. MO stock is up 40% year-to-date.

$MOHighAI 8/10

UBS raises Altria stock price target to $83 on strong quarter

UBS raised its price target on Altria Group (NYSE:MO) to $83, citing strong Q3 2026 revenue growth of 3.6% and raised EPS guidance. The stock trades near its 52-week high, up 43% over the past year. Altria's dividend yield is 5.79%, and it has raised dividends for 16 consecutive years. Recent earnings beat estimates, with EPS of $1.52 and revenue of $6.13 billion. Goldman Sachs and BofA Securities also raised their price targets.

$MOHighAI 8/10

What Just Happened To Altria Stock?

Altria (MO) shares rose 5.2% on October 29, 2026, after beating Q3 earnings estimates and raising its full-year guidance. The company reported adjusted earnings of $1.52 per share on $5.44 billion in revenue, exceeding forecasts. Management raised its 2026 earnings outlook to $5.66-$5.74 per share, up from prior guidance. The stock closed at $76.75, its highest in a year, with a 29.5% return over the past 12 months.